General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novartis Corporation(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(MODEST), Amgen(SIGNIFICANT), Corcept(SIGNIFICANT), Astra Zeneca(SIGNIFICANT), Boerhinger Ingelheim(SIGNIFICANT), Eli Lilly and Company(SIGNIFICANT), Esperion (SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), New Amsterdam(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Corsera(SIGNIFICANT) EQUITY INTERESTS/STOCK OPTIONS: Miga Health(SIGNIFICANT) OFFICER, DIRECTOR ETC: Physician Partners LLC(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Freedom Health, Inc(SIGNIFICANT), RXAdvance, LLC(SIGNIFICANT), Florida Medical Associates, LLC(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Alnylam(NONE), Merck & Co., Inc.(NONE), Bayer Healthcare Pharmaceuticals(NONE), Amgen(NONE), Boerhinger Ingelheim(NONE), Eli Lilly and Company(NONE), Novartis Corporation(NONE), Novo Nordisk Inc.(SIGNIFICANT)

View Full Disclosure